Incidence of Uveitis in Secukinumab‐treated Patients With Ankylosing Spondylitis: Pooled Data Analysis From Three Phase 3 Studies

OBJECTIVE: The objective of this study was to report the incidence of uveitis in secukinumab‐treated patients with ankylosing spondylitis (AS) in a pooled analysis of three phase 3 trials (MEASURE 1‐3 [ClinicalTrials.gov identifiers NCT01358175, NCT01649375, NCT02008916]). METHODS: Analysis included...

Descripción completa

Detalles Bibliográficos
Autores principales: Deodhar, Atul A., Miceli‐Richard, Corine, Baraliakos, Xenofon, Marzo‐Ortega, Helena, Gladman, Dafna D., Blanco, Ricardo, Das Gupta, Ayan, Martin, Ruvie, Safi, Jorge, Porter, Brian, Shete, Abhijit, Rosenbaum, James T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7231512/
https://www.ncbi.nlm.nih.gov/pubmed/32352653
http://dx.doi.org/10.1002/acr2.11139

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7231512/
https://www.ncbi.nlm.nih.gov/pubmed/32352653
http://dx.doi.org/10.1002/acr2.11139

Ejemplares similares